As of Q4'25, Intel's latest reported operating expenses show R&D Expenses at USD 3.2B and SG&A Expenses at USD 1.2B. This marks a continued decrease in both categories compared to previous quarters, with R&D down from USD 3.6B in Q1'25 and SG&A relatively stable after a slight dip in Q2'25. From Q1'23 to Q4'25, the chart reveals a clear downward trend in both R&D and SG&A expenses. R&D peaked at USD 4.4B in Q1'24 before steadily declining to USD 3.2B by Q4'25, while SG&A expenses, after reaching a high of USD 1.6B in Q4'23, have gradually decreased and stabilized around USD 1.1B–1.2B in the most recent quarters. This suggests ongoing cost optimization efforts over the observed period.